Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM
Condition(s) studied
Study summary
This multicenter pilot study will enroll adult participants with a confirmed clinical diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) and heart failure (HF) controls with documentation within the past 2 years that either excludes ATTR-CM or indicates a low probability of ATTR-CM. Ocular imaging and other study data will be collected to assess the feasibility of developing and preliminarily evaluating a machine learning model to discriminate ATTR-CM cases from HF controls without ATTR-CM.
Eligibility
Primary outcome measure(s)
- Comparison of per-participant confidence scores distributions between ATTR-CM cases and HF controls without ATTR-CM — At a single assessment time point within 90 days following informed consent form signing
Per-participant confidence score distributions generated by the machine learning (ML) model will be compared between participants with clinically confirmed transthyretin amyloid cardiomyopathy (ATTR-CM) and heart failure controls without ATTR-CM. - Qualitative assessment of features learned indicative of ATTR pathology — At a single assessment time point within 90 days following informed consent form signing
Features learned by the machine learning (ML) model that are indicative of transthyretin amyloid pathology will be qualitatively assessed.
Trial sites (20)
| Facility | City | Region | Status |
|---|---|---|---|
| Research Site | Palo Alto | California | Not Yet Recruiting |
| Research Site | Jacksonville | Florida | Not Yet Recruiting |
| Research Site | Chicago | Illinois | Not Yet Recruiting |
| Research Site | Boston | Massachusetts | Not Yet Recruiting |
| Research Site | Portland | Oregon | Not Yet Recruiting |
| Research Site | Germantown | Tennessee | Not Yet Recruiting |
| Research Site | Berlin | Germany | Not Yet Recruiting |
| Research Site | Essen | Germany | Not Yet Recruiting |
| Research Site | Frankfurt am Main | Germany | Not Yet Recruiting |
| Research Site | Würzburg | Germany | Not Yet Recruiting |
| Research Site | Guimarães | Portugal | Recruiting |
| Research Site | Lisbon | Portugal | Not Yet Recruiting |
| Research Site | Lisbon | Portugal | Not Yet Recruiting |
| Research Site | Lisbon | Portugal | Not Yet Recruiting |
| Research Site | L'Hospitalet de Llobregat | Spain | Not Yet Recruiting |
| Research Site | Madrid | Spain | Not Yet Recruiting |
| Research Site | Palma de Mallorca | Spain | Not Yet Recruiting |
| Research Site | Gothenburg | Sweden | Not Yet Recruiting |
| Research Site | Solna | Sweden | Not Yet Recruiting |
| Research Site | Vasterbottens Lan | Sweden | Not Yet Recruiting |
More AstraZeneca trials in Spain
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07690436 on ClinicalTrials.gov ↗ ← All trials in Spain